
New Laser Therapy Offers Drug-Free Relief for Tennis Elbow
A rigorous clinical trial shows that laser therapy successfully relieves pain from lateral epicondylitis (tennis elbow), giving 10.5 million people worldwide a new non-invasive treatment option. The FDA just cleared the device after 72% of patients experienced real relief.
Millions of people struggling with chronic elbow pain now have a scientifically proven treatment option that doesn't require drugs or surgery.
Multi Radiance Medical just received FDA clearance for their MR5 ACTIV PRO laser device to treat lateral epicondylitis, commonly known as tennis elbow. The approval follows a rigorous triple-blind clinical trial that showed impressive results for patients living with this painful condition.
Despite its nickname, tennis elbow affects far more workers than athletes. The condition hits about 10.5 million adults worldwide each year, mostly people whose jobs involve repetitive arm and hand movements. Construction workers, office employees, and anyone who performs daily activities that stress the forearm can develop the painful condition that makes gripping objects difficult and impacts quality of life.
The clinical trial delivered solid evidence that this treatment works. Researchers found that 72% of patients receiving the active laser treatment achieved meaningful pain relief, compared to just 40% of those receiving a placebo treatment. The study met the highest scientific standards as a randomized, triple-blind, placebo-controlled trial across multiple medical centers.
The device uses a combination of three light wavelengths to target pain without breaking the skin or requiring medication. Patients can receive treatment in a healthcare office without needles, pills, or recovery time.

The Ripple Effect
This FDA clearance represents more than just one new treatment option. It adds to a growing body of evidence that photobiomodulation therapy can effectively manage musculoskeletal pain without the risks associated with long-term medication use or invasive procedures.
The study results were published in BMJ Open, a respected peer-reviewed medical journal, making the full findings available to doctors and researchers worldwide. This transparency helps healthcare providers make informed decisions about treatment options for their patients.
Multi Radiance Medical already holds FDA clearances for using similar laser technology to treat fibromyalgia pain and neck and shoulder pain. Each clearance required rigorous clinical testing and regulatory review, building a foundation of evidence-based treatment options.
For the millions of people whose elbow pain interferes with work, hobbies, and everyday tasks like opening jars or shaking hands, this validated treatment offers genuine hope. Healthcare providers can now offer patients a clinically proven alternative that works with the body's natural healing processes rather than masking symptoms with medication.
When scientific research meets real patient needs, everyone wins.
More Images




Based on reporting by Google News - Clinical Trial Success
This story was written by BrightWire based on verified news reports.
Spread the positivity!
Share this good news with someone who needs it


